logo
15:57 Feb 25

Hikal Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
200.89
+0.33 (+0.16%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Hikal Ltd. Financials

Hikal Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
200.89
+0.33 (+0.16%)
15:57 Feb 25
Quality
image/svg+xml

73/100
High Financial Strength

Valuation
image/svg+xml

30/100
Expensive Valuation

Technical

33/100
Technically Bearish

Strength

5

Weakness

3

Opportunity

2

Threats

0

7.19 %

ROE %

3.59 %

ROA %

-1.05

EPS

102.21

BVPS

4.88 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
1942.72 2023.03 1784.6 1859.8 1745.6
Operating Expenses +
1602.16 1765.97 1517.57 1531.4 1507.2
Raw Material
1032.21 1121.59 805.15 882.7 799
Increase Decrease in Cost
-35.82 -14.56 19.51 -45.4 -21.7
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
203.38 222.44 246.53 247.1 266.5
Miscellaneous Expenses
402.39 436.5 446.38 447 463.4
Operating Profit
340.56 257.06 267.03 328.4 238.4
Other Income
4.89 5.41 2.45 5 6.2
Depreciation
95.67 109.01 117.61 134.4 159.5
Interest
31.22 48.1 56.37 75.2 65.4
Profit before tax and exceptio..
218.56 105.36 95.5 123.8 19.7
Exceptional Items
0 0 0 0 -38
PBT
218.56 105.36 95.5 123.8 57.7
Provision for Taxation
58.06 26.98 25.9 33 -5.3
Net Profit
160.5 78.38 69.6 90.8 -13
NET Profit after MI
160.5 78.38 69.6 90.8 -13
EPS
13.02 6.36 5.64 7.36 -1.06
Operating Profit Margin (%)
17.53 12.71 14.96 17.66 13.66
Net Profit Margin (%)
8.26 3.87 3.9 4.88 -0.74

Hikal Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 68.80 68.80 68.80 68.80 68.80 68.80
FII 2.30 4.20 5.40 5.70 6.10 6.80
Public 7.10 5.20 4.00 3.80 3.40 3.60
Others 21.80 21.80 21.80 21.70 21.70 20.80
Shareholder Shares Holding %
Research 360 logo
Download Our App On: